Entering text into the input field will update the search result below

Annexon stock gains premarket on extension of cash runway into 2025

Jul. 12, 2022 8:58 AM ETAnnexon, Inc. (ANNX) StockBy: Jessica Kuruthukulangara, SA News Editor
  • Annexon (NASDAQ:ANNX) stock gained 10% premarket on Tuesday after the biopharmaceutical firm extended its cash runway into H2 of 2025 following the closing of a $130M private placement.
  • Proceeds from the private placement, along with ANNX's current cash, cash equivalents and marketable securities, are expected to fund

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About ANNX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Annexon, Inc.
Tenaya Therapeutics, Inc.
Nkarta, Inc.
Design Therapeutics, Inc.
CEL-SCI Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.